Juvenile Arthritis

Top Story

FDA approves Actemra subcutaneous injection for active systemic JIA

FDA approves Actemra subcutaneous injection for active systemic JIA
September 13, 2018
In the Journals

Disease activity, corticosteroids raise risk for preterm delivery in pregnant women with RA, JIA

September 13, 2018
The increased risk for preterm delivery among pregnant woman with rheumatoid arthritis and juvenile idiopathic arthritis is partially tied to maternal disease activity…

ACR report card: Majority of states score 'C' for rheumatology care

September 4, 2018
The 2018 Rheumatic Disease Report Card: Raising the Grade on Rheumatology Care in America released today by the American College of Rheumatology demonstrates that…

A Diagnosis Divided

August 31, 2018
We begin with a 24-year-old previously healthy female presenting with gradual worsening — over the last few months — migraine-like headaches accompanied by…
More Headlines »
CME

Rheumatic Immune-related Adverse Events: Multidisciplinary Perspectives on Recognition and Management

This activity is supported by an educational grant from Bristol-Myers Squibb.

The introduction of immune checkpoint inhibitors has had a great impact on the field of oncology. However, these new…
More »
Video
Meeting News Coverage

VIDEO: Silverman discusses immunology links between cancer treatments and rheumatic diseases

March 15, 2016
More »
Resource Centers
Rheumatology Nurses Society Annual Conference

Rheumatology Nurses Society Annual Conference

CME ABIM MOC

Ace the Case: A 55-Year-Old Man With RA and Increasing Joint Symptoms After Methotrexate Use

There is no commercial support for this activity.

This educational activity will discuss the management of a 55-year-old man with rheumatoid arthritis and increasing…
More »